Oligometastatic prostate cancer
Clinical trials for Oligometastatic prostate cancer explained in plain language.
Never miss a new study
Get alerted when new Oligometastatic prostate cancer trials appear
Sign up with your email to follow new studies for Oligometastatic prostate cancer, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Radiation boost may extend Drug-Free time in prostate cancer recurrence
Disease control Not yet recruitingThis trial tests whether adding targeted radiation to standard hormone therapy can help men with recurring prostate cancer stay off cancer drugs longer. Men with a rising PSA and 1 to 5 metastases will receive either hormone therapy alone or hormone therapy plus radiation to the …
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER
Phase 3 • Sponsor: Ente Ospedaliero Cantonale, Bellinzona • Aim: Disease control
Last updated Aug 26, 2026 00:00 UTC
-
Triple attack on prostate cancer: drug, surgery, and radiation aim to stop spread
Disease control Not yet recruitingThis study tests whether adding surgery and targeted radiation to a new hormone-blocking drug (rezvilutamide) can help men whose prostate cancer has spread to a few spots (oligometastatic). 300 men will be split into three groups: one gets the drug alone, one gets drug plus surge…
Matched conditions: OLIGOMETASTATIC PROSTATE CANCER
Phase 2 • Sponsor: Fudan University • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC